ArticleDiabetic medicine : a journal of the British Diabetic Association2026
Policy gaps in type 1 diabetes: A UK audit of National Governing Bodies.
Article in Diabetic medicine : a journal of the British Diabetic Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsNational Governing Bodies (NGBs) for sport in the United Kingdom (UK) are responsible for setting standards and ensuring safe, inclusive participation for all, including people with type 1 diabetes (T1D). This audit systematically assessed the extent and quality of policy provision among UK-based NGBs, focusing on support for athletes with T1D. The findings were compared with epilepsy, asthma and allergies to evaluate equity and consistency in safeguarding and inclusion practices.
methodsA systematic policy audit of UK sport NGBs to assess the presence and content of policies addressing athletes with T1D, asthma, epilepsy and allergies. Policy documents were accessed through public materials on NGB websites. NGBs were contacted by email to confirm the existence of relevant policies and to request any documents not currently included on their website. Sports were included if their NGB had a publicly accessible website.
resultsOf 185 NGBs, 20 (11%) had policy documents mentioning diabetes, 14 (7.7%) asthma, 12 (6.6%) epilepsy and 4 (2.2%) allergies. Of the 20 NGBs with documents mentioning diabetes, only 4 had dedicated diabetes policies. The remaining 16 referred to diabetes in broader documents.
conclusionDespite increasing emphasis on inclusion in sport, few NGBs have clear policies to support individuals with diabetes. This is also the case for asthma, epilepsy and allergies. We recommend the development of national policies for diabetes, which can be adapted by individual sporting bodies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.